3d
IFLScience on MSNA New Synthetic Cannabinoid Could Pack A Painkilling Punch – Without The HighThe way they did it was to design a custom, synthetic cannabinoid molecule that is positively charged, which prevents it from being able to cross the blood-brain barrier. This means it can’t bind to ...
Poisonings linked to synthetic and semisynthetic cannabinoids (man-made products designed to mimic cannabis) are increasing ...
Cannabinoid-induced poisonings are leading to more hospital admissions as drug traffickers target puff bars, gummies, and ...
Cresco Labs CRLBF reported fourth-quarter revenue of $175.91 million, surpassing estimates of $172.13 million but marking a ...
Synthetic cannabinoids, a class of new psychoactive substances, bind to cannabinoid receptors CB1 and CB2 much more strongly than tetrahydrocannabinol (THC) and cannabidiol (CBD), raising public ...
3d
AZoLifeSciences on MSNNew Cannabinoid Drug Brings Hope For Treating Chronic Pain Without AddictionVIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...
A survey of individuals with cannabinoid hyperemesis syndrome reveals high rates of emergency care and hospitalizations, with ...
3d
HealthDay on MSNWeed Use During Pregnancy Triples Risk Of Behavioral Problems In KidsSome women turn to weed during pregnancy to help deal with common issues like nausea, sleep problem and stress.Unfo ...
Anebulo Pharmaceuticals, Inc.’s ANEB share price has surged by 19.58%, which has investors questioning if this is right time to sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results